Hyderabad-based Natco Pharma Ltd on Tuesday said it has received the
final approval from the US health regulator for its first supplemental
abbreviated new drug application (sANDA) filed from its new drug
formulations facility at Visakhapatnam, Andhra Pradesh.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/natco-pharma-gets-usfda-approval-for-visakhapatnam-facility/articleshow/75423966.cms
No comments:
Post a Comment